A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT)
Author(s) -
Gregory L. Sahlem,
W. Vaughn McCall,
E. Baron Short,
Peter B. Rosenquist,
James Fox,
Nagy A. Youssef,
Andrew Manett,
Suzanne E. U. Kerns,
Morgan Dancy,
Laryssa McCloud,
Mark S. George,
Harold A. Sackeïm
Publication year - 2020
Publication title -
brain stimulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 81
eISSN - 1935-861X
pISSN - 1876-4754
DOI - 10.1016/j.brs.2020.07.015
Subject(s) - electroconvulsive therapy , open label , anesthesia , pulse (music) , medicine , seizure threshold , randomized controlled trial , electroconvulsive shock , surgery , epilepsy , psychiatry , anticonvulsant , physics , detector , optics
Focal Electrically-Administered Seizure Therapy (FEAST) is a form of electroconvulsive therapy (ECT) that spatially focuses the electrical stimulus to initiate seizure activity in right prefrontal cortex. Two open-label non-comparative studies suggested that FEAST has reduced cognitive side effects when compared to historical data from other forms of ECT. In two different ECT clinics, we compared the efficacy and cognitive side effects of FEAST and Right Unilateral Ultrabrief Pulse (RUL-UBP) ECT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom